Corvus Pharmaceuticals, Inc.

NASDAQ:CRVS

Biotechnology

Healthcare
$10.17 -1.58%

-$0.19 today

Market cap
$857.87M
Beta
0.84
P/E (TTM)
-24.1
EPS (TTM)
-$0.49
52W Low $3.55High $26.95

Volume 0.93M

Average 1.49M

Price history

Corvus Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+11.88%

Period high

$25.52

Period low

$6.50

Latest

$10.17

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 13, 2026Nov 13, 2026
SC 13GNov 10, 2026Nov 10, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13GAug 7, 2026Aug 7, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
SC 13G/AJul 27, 2026Jul 27, 2026
8-KJul 22, 2026Jul 22, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
8-KJun 12, 2026Jun 12, 2026

Competitors

Who does Corvus Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CRVS's filings, answered from its disclosures.

What is the latest CRVS filing?

The latest filing shown is 4 dated Nov 13, 2026.

How many recent filings does CRVS have?

Intrinsic Alpha currently shows 20 recent filings for CRVS.